Medicaid-Covered Peer Support Services Used by Enrollees With Opioid Use Disorder.  Bao Y, Zhang H, Hutchings K, Harris RA, Calderbank T, Schackman BR.  JAMA Netw Open. 2024;7(7):e2420737. doi:10.1001/jamanetworkopen.2024.20737 https:...

Availability of Medications for Opioid Use Disorder in Community Mental Health Facilities.  Cantor J, Griffin BA, Levitan B, et al.  JAMA Netw Open. 2024;7(6):e2417545. doi:10.1001/jamanetworkopen.2024.17545 https://jam...

Buprenorphine deaths confirmed by toxicology reveal a low proportion of opioid agonist treatment before death in Finland.  Mariottini C, Häkkinen M, Kriikku P, Ojanperä I. Int J Legal Med. 2024 Jun 24. doi: 10.1007/s00414-024-03273-5. Epub ...

Treatment non-adherence among methadone maintenance patients and associated factors: a multicenter, cross-sectional study in Vietnam.  Nguyen HTT, Dinh DX.  Harm Reduct J. 2024 Jul 3;21(1):129. doi: 10.1186/s12954-024-01040-8. PMID: 38...

Treatment for Opioid Use Disorder: Population Estimates - United States, 2022.  Dowell D, Brown S, Gyawali S, Hoenig J, Ko J, Mikosz C, Ussery E, Baldwin G, Jones CM, Olsen Y, Tomoyasu N, Han B, Compton WM, Volkow ND.  MMWR Morb Mortal...

Payment-related barriers to medications for opioid use disorder: A critical review of the literature and real-world application.  Bowser D, Bohler R, Davis MT, Hodgkin D, Horgan C.  J Subst Use Addict Treat. 2024 Jun 19:209441. doi: 10...